Home › NDC Lookup › Labelers › Genentech, Inc.

Genentech, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 50242 (Genentech, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

136
Package NDCs
105
Products
105
Active listings
0
Discontinued
38
Ingredients
0
Therapeutic classes
17
Dosage forms
5
With NADAC pricing

Portfolio

Top ingredients
Mosunetuzumab 10
omalizumab 9
tocilizumab 7
emicizumab 6
BALOXAVIR MARBOXIL 5
polatuzumab vedotin 5
bevacizumab 4
Ranibizumab 4
Glofitamab 4
ENTRECTINIB 3
By dosage form
INJECTION, SOLUTION 36
LIQUID 11
INJECTION, POWDER, LYOPHILIZED, FO... 8
TABLET, FILM COATED 8
CAPSULE 6
INJECTION 6
CONCENTRATE 6
KIT 5

Browse records — 105 products

Drug / product Billing NDC NADAC / unit Status
ACTEMRA tocilizumab 200 mg/10mL INJECTION, SOLUTION, CONCENTRATE Genentech, · NDC 50242-0136-01 · J3262 · 1 VIAL, SINGLE-USE in 1 BOX (50242-136-01) / 10 mL in 1 VIAL, SINGLE-USE 50242-0136-01 — On market View →
ACTEMRA tocilizumab 400 mg/20mL INJECTION, SOLUTION, CONCENTRATE Genentech, · NDC 50242-0137-01 · J3262 · 1 VIAL, SINGLE-USE in 1 BOX (50242-137-01) / 20 mL in 1 VIAL, SINGLE-USE 50242-0137-01 — On market View →
ACTEMRA tocilizumab 80 mg/4mL INJECTION, SOLUTION, CONCENTRATE Genentech, · NDC 50242-0135-01 · J3262 · 1 VIAL, SINGLE-USE in 1 BOX (50242-135-01) / 4 mL in 1 VIAL, SINGLE-USE 50242-0135-01 — On market View →
Actemra tocilizumab 162 mg/.9mL INJECTION, SOLUTION Genentech, · NDC 50242-0138-01 · 1 SYRINGE, GLASS in 1 BOX (50242-138-01) / .9 mL in 1 SYRINGE, GLASS 50242-0138-01 — On market View →
Actemra ACTPen tocilizumab 162 mg/.9mL INJECTION, SOLUTION Genentech, · NDC 50242-0143-01 · 1 SYRINGE, GLASS in 1 BOX (50242-143-01) / .9 mL in 1 SYRINGE, GLASS 50242-0143-01 $1,279.060 /unit · NADAC On market View →
Activase Alteplase KIT Genentech, · NDC 50242-0044-13 · J2997 · 1 KIT in 1 CARTON (50242-044-13) * 50 mL in 1 VIAL, SINGLE-USE * 50 mL in 1 VIAL, SINGLE-USE 50242-0044-13 — On market View →
Activase Alteplase KIT Genentech, · NDC 50242-0085-27 · J2997 · 1 KIT in 1 CARTON (50242-085-27) * 100 mL in 1 VIAL, SINGLE-USE * 100 mL in 1 VIAL, SINGLE-USE 50242-0085-27 — On market View →
ALECENSA ALECTINIB HYDROCHLORIDE 150 mg/1 CAPSULE Genentech, · NDC 50242-0130-01 · 1 BOTTLE, PLASTIC in 1 CARTON (50242-130-01) / 240 CAPSULE in 1 BOTTLE, PLASTIC 50242-0130-01 — On market View →
ALECENSA ALECTINIB HYDROCHLORIDE 150 mg/1 CAPSULE Genentech, · NDC 50242-0130-01 · 1 BOTTLE, PLASTIC in 1 CARTON (50242-130-01) / 240 CAPSULE in 1 BOTTLE, PLASTIC 50242-0130-01 — On market View →
Astegolimab 140 mg/.001L LIQUID Genentech, · NDC 50242-0400-01 · 120 L in 1 TANK (50242-400-01) 50242-0400-01 — On market View →
Avastin bevacizumab 100 mg/4mL INJECTION, SOLUTION Genentech, · NDC 50242-0060-01 · J9035 · 1 VIAL, SINGLE-USE in 1 CARTON (50242-060-01) / 4 mL in 1 VIAL, SINGLE-USE 50242-0060-01 — On market View →
Avastin bevacizumab 400 mg/16mL INJECTION, SOLUTION Genentech, · NDC 50242-0061-01 · J9035 · 1 VIAL, SINGLE-USE in 1 CARTON (50242-061-01) / 16 mL in 1 VIAL, SINGLE-USE 50242-0061-01 — On market View →
bevacizumab 25 g/L LIQUID Genentech, · NDC 50242-0059-01 · 120 L in 1 TANK (50242-059-01) 50242-0059-01 — On market View →
Bevacizumab 25 g/L LIQUID Genentech, · NDC 50242-0160-01 · 120 L in 1 TANK (50242-160-01) 50242-0160-01 — On market View →
Cathflo Activase Alteplase 2.2 mg/2mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Genentech, · NDC 50242-0041-10 · J2997 · 10 VIAL in 1 CARTON (50242-041-10) / 2 mL in 1 VIAL 50242-0041-10 — On market View →
Columvi Glofitamab 10 mg/10mL CONCENTRATE Genentech, · NDC 50242-0127-01 · J9286 · 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-127-01) / 10 mL in 1 VIAL, SINGLE-DOSE 50242-0127-01 — On market View →
Columvi Glofitamab 2.5 mg/2.5mL SOLUTION, CONCENTRATE Genentech, · NDC 50242-0125-01 · J9286 · 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-125-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE 50242-0125-01 — On market View →
Columvi Glofitamab 10 mg/10mL CONCENTRATE Genentech, · NDC 50242-0127-01 · J9286 · 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-127-01) / 10 mL in 1 VIAL, SINGLE-DOSE 50242-0127-01 — On market View →
Columvi Glofitamab 2.5 mg/2.5mL SOLUTION, CONCENTRATE Genentech, · NDC 50242-0125-01 · J9286 · 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-125-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE 50242-0125-01 — On market View →
Cotellic COBIMETINIB 20 mg/1 TABLET, FILM COATED Genentech, · NDC 50242-0717-01 · 63 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50242-717-01) 50242-0717-01 — On market View →
Cotellic COBIMETINIB 20 mg/1 TABLET, FILM COATED Genentech, · NDC 50242-0717-01 · 63 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50242-717-01) 50242-0717-01 — On market View →
dornase alfa 14 g/L LIQUID Genentech, · NDC 50242-0099-01 · 120 L in 1 TANK (50242-099-01) 50242-0099-01 — On market View →
Enspryng Satralizumab 120 mg/mL INJECTION, SOLUTION Genentech, · NDC 50242-0007-01 · 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-01) / 1 mL in 1 SYRINGE, PLASTIC 50242-0007-01 — On market View →
Enspryng Satralizumab 120 mg/mL INJECTION, SOLUTION Genentech, · NDC 50242-0007-01 · 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-01) / 1 mL in 1 SYRINGE, PLASTIC 50242-0007-01 — On market View →
ERIVEDGE vismodegib 150 mg/1 CAPSULE Genentech, · NDC 50242-0140-01 · 1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) / 28 CAPSULE in 1 BOTTLE, PLASTIC 50242-0140-01 — On market View →
ESBRIET PIRFENIDONE 801 mg/1 TABLET, COATED Genentech, · NDC 50242-0123-01 · 1 BOTTLE, PLASTIC in 1 CARTON (50242-123-01) / 90 TABLET, COATED in 1 BOTTLE, PLASTIC 50242-0123-01 — On market View →
ESBRIET PIRFENIDONE 267 mg/1 TABLET, COATED Genentech, · NDC 50242-0122-06 · 1 BOTTLE, PLASTIC in 1 CARTON (50242-122-06) / 270 TABLET, COATED in 1 BOTTLE, PLASTIC 50242-0122-06 — On market View →
EVRYSDI Risdiplam .75 mg/mL POWDER, FOR SOLUTION Genentech, · NDC 50242-0175-07 · 1 BOTTLE, GLASS in 1 CARTON (50242-175-07) / 80 mL in 1 BOTTLE, GLASS 50242-0175-07 — On market View →
EVRYSDI Risdiplam 5 mg/1 TABLET Genentech, · NDC 50242-0202-01 · 1 BOTTLE, PLASTIC in 1 CARTON (50242-202-01) / 30 TABLET in 1 BOTTLE, PLASTIC 50242-0202-01 — On market View →
Gavreto Pralsetinib 100 mg/1 CAPSULE Genentech, · NDC 50242-0210-60 · 1 BOTTLE in 1 CARTON (50242-210-60) / 60 CAPSULE in 1 BOTTLE 50242-0210-60 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.